Results 311 to 320 of about 1,223,971 (333)

Clinical importance of neutralising antibodies against interferon beta in patients with relapsing-remitting multiple sclerosis

Lancet, The, 2003
Per Soelberg Sørensen, Thor Petersen, Egon Stenager   +2 more
exaly  

Comparative therapeutic efficacy of remdesivir and combination lopinavir, ritonavir, and interferon beta against MERS-CoV

Nature Communications, 2020
Timothy P Sheahan, Sarah R Leist, John Won   +2 more
exaly  

Size, time-varying beta, and conditional heteroscedasticity in UK stock returns

, 1999
Mario G. Reyes
semanticscholar   +1 more source

Cross‐sectional analysis of Swedish stock returns with time‐varying beta: the Swedish stock market 1983–96

, 2000
Hossein Asgharian, B. Hansson
semanticscholar   +1 more source

Beta-Diversity in Tropical Forest Trees

Science, 2002
Richard Condit, Nigel Pitman, Jerome Chave   +2 more
exaly  

Interferon beta-1a for brain tissue loss in patients at presentation with syndromes suggestive of multiple sclerosis: a randomised, double-blind, placebo-controlled trial

Lancet, The, 2004
Massimo Filippi, Marco Rovaris, Matilde Inglese   +2 more
exaly  

The Stochastic Structure of the Time–Varying Beta: Evidence from UK Companies

, 2002
Taufiq Choudhry
semanticscholar   +1 more source

CAPM and Time-Varying Beta: The Cross-Section of Expected Returns

, 2007
D. Basu, A. Stremme
semanticscholar   +1 more source

A weak signal for strong responses: interferon-alpha/beta revisited

Nature Reviews Molecular Cell Biology, 2001
Tadatsugu Taniguchi, Akinori Takaoka
exaly  

The industrial relationships in time-varying beta coefficients between Korea and United States

, 2009
K. Park, Myeong Hwan Kim
semanticscholar   +1 more source